AIM IMMUNOTECH INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AIM IMMUNOTECH INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $537.00K, a 411.43% increase year-over-year.
- AIM IMMUNOTECH INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $2.00M, a 203.18% increase year-over-year.
- AIM IMMUNOTECH INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $105.00K, a 80.26% decline year-over-year.
- AIM IMMUNOTECH INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $660.00K, a 100.61% increase year-over-year.
- AIM IMMUNOTECH INC. stock issued during period, value, new issues for fiscal 2025 was $984.00K, a 10.31% increase from fiscal 2024.
- AIM IMMUNOTECH INC. stock issued during period, value, new issues for fiscal 2024 was $892.00K, a 83.92% increase from fiscal 2023.
- AIM IMMUNOTECH INC. stock issued during period, value, new issues for fiscal 2023 was $485.00K, a 506.25% increase from fiscal 2022.
- AIM IMMUNOTECH INC. stock issued during period, value, new issues for fiscal 2022 was $80.00K, a 99.39% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $537.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $2.00M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $984.00K 10-K · filed 2026-03-27 | |
| 2025-06-30 | $105.00K 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $660.00K 10-Q · filed 2026-08-07 | |
| 2024-12-31 | $892.00K 10-K · filed 2026-03-27 | |
| 2024-09-30 | $180.00K 10-Q · filed 2025-11-17 | $1.19M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $532.00K 10-Q · filed 2025-11-17 | $1.24M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-03-31 | $329.00K 10-Q · filed 2025-11-17 | $714.00K derived: sum of 4 quarters · filed 2025-11-17 |
| 2023-12-31 | $147.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $485.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $233.00K 10-Q · filed 2024-11-14 | $338.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $5.00K 10-Q · filed 2024-11-14 | $130.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-03-31 | $100.00K 10-Q · filed 2024-11-14 | $180.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $80.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $25.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $55.00K 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $13.04M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $30.00K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $12.89M 10-Q · filed 2022-11-14 | $48.33M derived: sum of 4 quarters · filed 2022-11-14 |
| 2020-12-31 | $3.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $61.25M 10-K · filed 2022-03-31 |
| 2020-09-30 | $17.24M 10-Q · filed 2021-11-15 | $55.53M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $15.02M 10-Q · filed 2021-11-15 | $48.72M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-03-31 | $25.76M 10-Q · filed 2021-11-15 | $38.02M derived: sum of 4 quarters · filed 2021-11-15 |
| 2019-12-31 | -$2.49M derived: 10-K 12 month − 10-K 9 month · filed 2020-03-30 | $14.46M 10-K · filed 2020-03-30 |
| 2019-09-30 | $10.43M derived: 10-K 9 month − 10-Q 6 month · filed 2021-03-31 | $16.32M derived: sum of 4 quarters · filed 2021-03-31 |
| 2019-06-30 | $4.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $6.03M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $2.21M 10-Q · filed 2020-05-14 | $2.67M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$636.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $2.78M 10-K · filed 2020-03-30 |
| 2018-09-30 | $139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $3.42M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $953.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $3.34M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $2.33M 10-Q · filed 2019-05-15 | $3.63M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $2.18M 10-K · filed 2019-04-01 |
| 2017-09-30 | $65.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $6.53M derived: sum of 4 quarters · filed 2018-03-30 |
| 2017-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $6.47M derived: sum of 4 quarters · filed 2018-03-30 |
| 2017-03-31 | $875.00K 10-Q · filed 2017-05-15 | $5.39M derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-12-31 | $4.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $4.52M 10-K · filed 2018-03-30 |
| 2016-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $175.00K derived: sum of 4 quarters · filed 2017-03-31 |
| 2016-06-30 | $161.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $551.00K derived: sum of 4 quarters · filed 2017-03-31 |
| 2016-03-31 | $2.00K 10-Q · filed 2016-05-16 | $4.44M derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $9.68M 10-K · filed 2017-03-31 |
| 2015-09-30 | $387.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $12.73M derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-06-30 | $4.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $13.65M derived: sum of 4 quarters · filed 2017-03-31 |
| 2015-03-31 | $5.24M 10-Q · filed 2015-05-12 | $11.67M derived: sum of 4 quarters · filed 2017-03-31 |
| 2014-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $12.82M 10-K · filed 2017-03-31 |
| 2014-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | |
| 2014-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | |
| 2014-03-31 | $6.38M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $249.00K 10-K · filed 2016-03-29 | |
| 2012-12-31 | $13.73M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $23.00M 10-K · filed 2015-03-19 |
| 2010-12-31 | $292.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |